One of the challenges associated with the use of stentbased MIGS is that the location of increased aqueous outflow resistance is often unclear: when targeting a small area of the outflow system with stent-based MIGS there is a risk that the area of blockage will be missed or sub optimally treated.
A comprehensive MIGS procedure, ABiC accesses, catheterises, and viscodilates the trabecular meshwork, Schlemm’s canal, and importantly, the distal outflow system, beginning with the collector channels. Put simply, Ellex says “ABiC with iTrack is the only MIGS that comprehensively addresses all aspects of potential outflow resistance – thus removing the guesswork inherent in other MIGS procedures to achieve an average reduction in mean IOP of 30 per cent, combined with a 50 per cent reduction in medication burden”.
Contact: www.ellex.com/iTRACK
